Funding for this research was provided by:
jeffrey modell foundation
Article History
Accepted: 22 February 2022
First Online: 15 March 2022
Declarations
:
: N/A
: N/A
: N/A
: Dr. Forbes Satter: consulting and advisory board for Horizon, CSL Behring, Takeda, and ADMA. Dr. Leiding: Advisory Board: CSL-Behring, Horizon Therapeutics, Orchard Therapeutics; Consultant: Pharming; Research Grant: Prometic, Horizon Pharma; Speaker: Actimmune, CSL-Behring, Horizon Therapeutics.